Financials DVx Inc.

Equities

3079

JP3548710007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
996 JPY -0.50% Intraday chart for DVx Inc. -0.30% -6.39%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 14,244 10,770 10,251 10,440 10,156 9,842
Enterprise Value (EV) 1 8,262 5,558 5,049 3,955 2,310 1,237
P/E ratio 16.6 x 10.8 x 12 x 19.2 x 12.4 x 11.2 x
Yield - - - - - -
Capitalization / Revenue 0.37 x 0.27 x 0.23 x 0.25 x 0.22 x 0.21 x
EV / Revenue 0.22 x 0.14 x 0.11 x 0.1 x 0.05 x 0.03 x
EV / EBITDA 5.48 x 3.81 x 3.62 x 3.2 x 1.43 x 0.71 x
EV / FCF 9.83 x 30.9 x 8 x 2.77 x 1.37 x 1 x
FCF Yield 10.2% 3.23% 12.5% 36.1% 73.1% 100%
Price to Book 1.93 x 1.39 x 1.24 x 1.39 x 1.25 x 1.12 x
Nbr of stocks (in thousands) 11,278 11,277 11,277 9,803 9,803 9,803
Reference price 2 1,263 955.0 909.0 1,065 1,036 1,004
Announcement Date 6/28/18 6/27/19 6/25/20 6/28/21 6/29/22 6/28/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 38,275 40,380 44,653 41,007 45,496 47,483
EBITDA 1 1,508 1,458 1,396 1,234 1,618 1,731
EBIT 1 1,334 1,238 1,114 848 1,252 1,340
Operating Margin 3.49% 3.07% 2.49% 2.07% 2.75% 2.82%
Earnings before Tax (EBT) 1 1,225 1,347 1,096 845 1,258 1,350
Net income 1 856 974 792 572 863 936
Net margin 2.24% 2.41% 1.77% 1.39% 1.9% 1.97%
EPS 2 75.90 88.45 75.56 55.50 83.33 90.04
Free Cash Flow 1 840.8 179.8 631.2 1,429 1,688 1,238
FCF margin 2.2% 0.45% 1.41% 3.48% 3.71% 2.61%
FCF Conversion (EBITDA) 55.75% 12.33% 45.22% 115.8% 104.3% 71.49%
FCF Conversion (Net income) 98.22% 18.45% 79.7% 249.83% 195.54% 132.21%
Dividend per Share - - - - - -
Announcement Date 6/28/18 6/27/19 6/25/20 6/28/21 6/29/22 6/28/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 22,121 19,310 22,032 11,969 11,773 23,618 11,917 11,604 22,632 11,611
EBITDA - - - - - - - - - -
EBIT 1 446 245 522 418 208 598 349 191 323 127
Operating Margin 2.02% 1.27% 2.37% 3.49% 1.77% 2.53% 2.93% 1.65% 1.43% 1.09%
Earnings before Tax (EBT) 1 454 243 524 420 214 612 345 194 337 -170
Net income 1 314 162 359 290 149 416 236 131 233 -119
Net margin 1.42% 0.84% 1.63% 2.42% 1.27% 1.76% 1.98% 1.13% 1.03% -1.02%
EPS 2 29.39 15.84 34.89 28.03 14.48 40.19 22.73 12.68 22.39 -11.45
Dividend per Share - - - - - - - - - -
Announcement Date 10/30/19 10/30/20 11/1/21 1/31/22 8/1/22 10/31/22 1/31/23 7/31/23 10/31/23 1/31/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 5,982 5,212 5,202 6,485 7,846 8,605
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 841 180 631 1,429 1,688 1,238
ROE (net income / shareholders' equity) 12.1% 13.1% 10.5% 7.39% 10.5% 10.5%
ROA (Net income/ Total Assets) 4.9% 4.27% 3.57% 2.59% 3.66% 3.66%
Assets 1 17,459 22,827 22,185 22,090 23,590 25,593
Book Value Per Share 2 654.0 689.0 736.0 769.0 830.0 896.0
Cash Flow per Share 2 540.0 489.0 509.0 630.0 758.0 829.0
Capex 1 271 173 368 248 111 229
Capex / Sales 0.71% 0.43% 0.82% 0.6% 0.24% 0.48%
Announcement Date 6/28/18 6/27/19 6/25/20 6/28/21 6/29/22 6/28/23
1JPY in Million2JPY
Estimates